Analytica Chimica Acta, 2021.
L. Labied, P. Rocchi, T. Doussineau, et al.
Archives Publications 2021
Quantitative tissue pharmacokinetics and EPR effect of AGuIX® nanoparticles: a multimodal imaging study in an orthotopic glioblastoma rat model and healthy macaque
Adv Healthc Mater., 2021, 1, e2100656.
V.-L. Tran, F. Lux, N. Tournier, et al.
3D Spatial Distribution of Nanoparticles in Mice Brain Metastases by X-ray Phase-Contrast Tomography
Frontiers in Oncology, 2021, 11, 55466.
E. Longo, L. Sancey, A. Cedola, et al.
Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D in vitro platform
Lab on a Chip, 2021, 21, 2495-2510.
S. Goodarzi, A. Prunet, F. Rossetti, et al.
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)
Radiother Oncol., 2021, 160, 159-165.
C. Verry, S. Dufort, J. Villa, et al.
Rapid evaluation of novel therapeutic strategies using a 3D collagen-based tissue-like model
Front. Bioeng. Biotechnol., 2021, 9, 53.
P. Maury, E. Porcel, A. Mau, et al.
Taylor dispersion analysis coupled to inductively coupled plasma mass spectrometry for ultrasmall nanoparticle size measurement : from drug product to biological media studies
Anal. Chem., 2021, 93, 1254-1259.
L. Labied, P. Rocchi, T. Doussineau, et al.
Unique features of brain metastases – targeted AGuIX nanoparticles vs their constituents: a focus on glutamate-.GABA-ergic neurotransmission in cortex nerve terminals
Food Chem Toxicol., 2021, 149, 112004.
T. Borisova, N. Pozdnyakova, N. Krisanova, et al.